Sham Foam IPO

Sham Foam is a listed issue, offered in a price band of ₹130 to ₹130 per share, in lots of 2000 shares. Every figure below is taken from the issue's own filings and exchange disclosures.

Issue details

Price band

₹130 – ₹130

Lot size

2000 shares

Minimum investment

₹2,60,000

Issue size

₹40.48 Cr

Fresh issue

₹40.48 Cr

Offer for sale

—

Opens

11 Aug 2026

Closes

13 Aug 2026

Listing date

18 Aug 2026

Registrar

Alankit Assignments Ltd.

Symbol

SHAMFOAM

One lot of 2000 shares at the upper band price of ₹130 is ₹2,60,000 — the smallest retail application this issue accepts.

Lead managers: Corporate Makers Capital Ltd, Navigant Corporate Advisors Ltd.

Subscription status

How many times the issue has been applied for, by investor category, as reported by the exchange at 13 Aug 2026, 06:20 pm IST.

Grey market premium (GMP)

Latest reported GMP

₹0

Implied over upper band

0.00%

As of

17 Aug 2026, 07:05 pm IST

How the reported premium has moved. The trend matters more than any single reading — a premium that is drifting down into the close is a different signal from one holding firm.

Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.

Reported financials

As disclosed in the offer document. Figures in ₹ crore unless the filing states otherwise.

Strengths disclosed in the offer document

• Leveraging the experience of its promoter and employees.
• Possesses an in-house manufacturing facility supported by technology-driven processes.
• Has an extensive and well-developed pan-India sales and distribution network.
• Maintains long-standing relationships with its dealers.
• Focuses on quality and timely delivery of its products.

Risk factors disclosed in the offer document

• The company is involved in litigation proceedings, and an adverse outcome could impact its reputation, business, financial condition, results of operations, and cash flows.
• The registered office and manufacturing facility are located on leased premises, and failure to renew or relocate these agreements could adversely affect the business.
• The company's revenues are significantly dependent on a few customers, and an inability to maintain these relationships could adversely affect its results of operations.
• The company has experienced negative cash flows in certain financial years, which could adversely affect its financial condition and growth.
• Volatility in the supply and pricing of raw materials, or failure by suppliers to meet their obligations, may adversely affect the business, cash flows, financial condition, and results of operations.
• The company's business operations are concentrated in certain geographical regions, and adverse developments in these regions could significantly impact revenue and results of operations.
• Any shutdown of operations at the manufacturing facility may have an adverse effect on the business and results of operations.

These are the company's own disclosures, not Alphave's assessment. Read the offer document →

What this page will not tell you

Whether to apply

Alphave is NISM-certified, not a SEBI-registered research analyst. There is no rating, verdict or recommendation on this issue anywhere on this page.

What it will list at

Nobody knows, and GMP is not a forecast of it. It is an unofficial over-the-counter quote reported by third parties, shown here with its source time so you can judge how stale it is.

Your allotment

Allotment is decided by the registrar (Alankit Assignments Ltd.) after the issue closes. Track the whole calendar in the IPO Centre.

← All current and upcoming IPOs · Open the interactive Sham Foam terminal →